| Janssen-Cilag AG - Rybrevant 350 mg/7 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 68380 | | 01 | | Rybrevant 350 mg/7 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01FX18 | | | | 20.01.2022 | | |
|
| Composition |
| amivantamabum 350 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 80, dl-methioninum, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 7.0 ml corresp. natrium 17 µg. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Amivantamabum | 350mg / 7ml |
| | BAG: Active Agent | Dose |
|---|
| Amivantamabum | 350 mg |
| | | | Inactive agents |
|---|
| DL-Methionine | | Dinatrii Edetas | | Histidin Hydrochloride Monohydrate | | Histidine | | Polysorbatum 80 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 1193.25 | 1314.15 | A | SL | Yes |
|
